CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Sit Less Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05691452
NCT05691452N/ACompleted

Technology-Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes: A Pilot Study

Vanderbilt University·interventional·Posted Jan 20, 2023·Updated Mar 19, 2025

In Brief

A clinical study evaluating Sit Less Program for Type 2 Diabetes and 2 related conditions. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The purpose of this study is to develop and test an 8-week sedentary behavior reduction intervention ("Sit Less" program) for patients with type 2 diabetes. The program aims to reduce and break sitting times among this population using an objective activity monitor and mHealth. The investigators will test the program to help diabetes patients break up sitting time, reduce daily sitting time, and move more. The investigators will also study preliminary effects of the SB reduction intervention on light physical activity, cardiometabolic markers and patient-centered outcomes, and whether diabetes patients like the program and can follow it.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 20, 2023
Enrollment StartJan 24, 2023
Primary CompletionJan 5, 2024
Study CompletionJul 30, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.4 years ago

Interventions

Sit Less Programbehavioral

The intervention group will target a 120 minute per day reduction in sedentary behavior using an objective activity monitor and mHealth. Outcomes will be measured at baseline and post-intervention.